SERIOUS ALLERGIC REACTIONS / ANAPHYLAXIS, PROLONGED AND SEVERE CYTOPENIAS, AND RADIATION EXPOSURE
See full prescribing information for complete boxed warning.
- TRADE NAMES: Bexxar (Corixa, GSK); Iodine131 I-Tositumomab (MDS Nordion); Tositumomab
- INDICATIONS: Non-Hodgkin's lymphoma
- CLASS: Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor), Biologic, Monoclonal antibody
- HALF-LIFE: 8 days
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Abciximab, Argatroban, Cilostazol, Citalopram, Clopidogrel, Dabigatran, Eptifibatide, Meloxicam, Tinzaparin
- See adverse reactions attributed to class:
Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor)
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
